Search Results - "DISCAFANI, Carolyn"
-
1
Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase
Published in Cancer research (Chicago, Ill.) (01-06-2004)“…HER-2 belongs to the ErbB family of receptor tyrosine kinases, which has been implicated in a variety of cancers. Overexpression of HER-2 is seen in 25-30% of…”
Get full text
Journal Article -
2
Epidermal Growth Factor Receptor Variant III Mutations in Lung Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
Published in Proceedings of the National Academy of Sciences - PNAS (16-05-2006)“…The tyrosine kinase inhibitors gefitinib (Iressa) and erlotinib (Tarceva) have shown anti-tumor activity in the treatment of non-small cell lung cancer…”
Get full text
Journal Article -
3
Combinatorial chemoprevention of intestinal neoplasia
Published in Nature medicine (01-09-2000)“…A combination of two drugs afforded remarkable protection from intestinal neoplasia in APC(Min/+) mice, a murine model of human familial adenomatous polyposis…”
Get full text
Journal Article -
4
Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity
Published in Journal of medicinal chemistry (24-02-2005)“…A series of new 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitrile derivatives that function as irreversible inhibitors of human epidermal growth factor…”
Get full text
Journal Article -
5
Parallel synthesis and biological evaluation of 5,6,7,8-tetrahydrobenzothieno[2,3- d]pyrimidin-4(3H)-one cytotoxic agents selective for p21-deficient cells
Published in Bioorganic & medicinal chemistry letters (01-11-2005)“…A novel series of anti-proliferative agents containing the thieno[2,3- d]pyrimidin-4-one scaffold and the structure–activity relationship studies to improve…”
Get full text
Journal Article -
6
Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)
Published in Journal of medicinal chemistry (02-01-2003)“…A series of of 6,7-disubstituted-4-anilinoquinoline-3-carbonitrile derivatives that function as irreversible inhibitors of EGFR and HER-2 kinases have been…”
Get full text
Journal Article -
7
HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo
Published in Cancer research (Chicago, Ill.) (15-04-2003)“…Hemiasterlin is a natural product derived from marine sponges that, like other structurally diverse peptide-like molecules, binds to the Vinca-peptide site in…”
Get full text
Journal Article -
8
Synthesis and SAR of 6-chloro-4-fluoroalkylamino-2-heteroaryl-5-(substituted)phenylpyrimidines as anti-cancer agents
Published in Bioorganic & medicinal chemistry (2009)“…The synthesis and SAR of a series of 6-chloro-4-fluoroalkylamino-2-heteroaryl-5-(substituted)phenylpyrimidines as anti-cancer agents are described. This series…”
Get full text
Journal Article -
9
MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivo
Published in Molecular cancer therapeutics (01-09-2003)“…The taxanes, paclitaxel (PTX) and docetaxel (DTX), belong to a novel class of anticancer drugs that stabilize microtubules and lead to tumor cell death. While…”
Get full text
Journal Article -
10
Preclinical Pharmacologic Evaluation of MST-997, an Orally Active Taxane with Superior In vitro and In vivo Efficacy in Paclitaxel- and Docetaxel-Resistant Tumor Models
Published in Clinical cancer research (01-06-2006)“…Purpose: Because resistance to paclitaxel and docetaxel is frequently observed in the clinic, new anti-microtubule agents have been sought. The aim of this…”
Get full text
Journal Article -
11
Identification of 4-anilino-3-quinolinecarbonitrile inhibitors of mitogen-activated protein/extracellular signal-regulated kinase 1 kinase
Published in Molecular cancer therapeutics (01-06-2004)“…A high-throughput screen for Ras–mitogen-activated protein kinase (MAPK) signaling inhibitors identified two series (class 1 and 2 ) of substituted…”
Get full text
Journal Article -
12
Namenamicin, a New Enediyne Antitumor Antibiotic from the Marine Ascidian Polysyncraton lithostrotum
Published in Journal of the American Chemical Society (06-11-1996)“…Marine ascidians belonging to the family Didemnidae have proven a remarkable source of chemically diverse natural products with potent biological properties…”
Get full text
Journal Article -
13
Spiroxins, DNA cleaving antitumor antibiotics from a marine-derived fungus
Published in Tetrahedron letters (26-03-1999)“…The spiroxins ( 1–5) were purified from the culture extract of a marine-derived fungus. Their unique bisnaphthospiroketal structures were established by NMR…”
Get full text
Journal Article -
14
TTI-237 : A Novel Microtubule-Active Compound with In vivo Antitumor Activity
Published in Cancer research (Chicago, Ill.) (01-04-2008)“…5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine butanedioate…”
Get full text
Journal Article -
15
Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene
Published in Cancer research (Chicago, Ill.) (15-07-1991)“…Mutated ras genes are powerful transforming agents in vitro and are found in a wide variety of human tumors in vivo. We characterized the histopathology and…”
Get full text
Journal Article -
16
SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models
Published in Cancer research (Chicago, Ill.) (15-06-2005)“…Src up-regulation is a common event in human cancers. In colorectal cancer, increased Src levels are an indicator of poor prognosis, and progression to…”
Get full text
Journal Article -
17
6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity
Published in Journal of medicinal chemistry (16-08-2001)“…A series of new 6-substituted-4-(3-bromophenylamino)quinazoline derivatives that may function as irreversible inhibitors of epidermal growth factor receptor…”
Get full text
Journal Article -
18
Synthesis, SAR study and biological evaluation of novel pyrazolo[1,5- a]pyrimidin-7-yl phenyl amides as anti-proliferative agents
Published in Bioorganic & medicinal chemistry (01-03-2009)“…Checkpoint deficiency of malignant cells can be exploited in cancer drug discovery. Compounds that selectively kill checkpoint-deficient cells versus…”
Get full text
Journal Article -
19
Optimization of 4-Phenylamino-3-quinolinecarbonitriles as Potent Inhibitors of Src Kinase Activity
Published in Journal of medicinal chemistry (08-11-2001)“…Subsequent to the discovery of 4-[(2,4-dichlorophenyl)amino]-6,7-dimethoxy-3-quinolinecarbonitrile (1a) as an inhibitor of Src kinase activity (IC50 = 30 nM),…”
Get full text
Journal Article -
20
2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as Covalent-Binding, Irreversible Inhibitors of the Kinase Domain of Vascular Endothelial Growth Factor Receptor-2
Published in Journal of medicinal chemistry (01-12-2005)“…A series of 2-(quinazolin-4-ylamino)-[1,4] benzoquinone derivatives that function as potent covalent-binding, irreversible inhibitors of the kinase domain of…”
Get full text
Journal Article